FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Zollinger

Research Profile

Physiology

Biotransformation

Chemicals & Drugs

Concepts & Ideas

Anatomy

Genes & Molecular Sequences

Molecular Structure

Procedures

Phenomena

Oxidation-Reduction

Living Beings

Disorders

Relapsing-Remitting Multiple Sclerosis

Co-author Network

Publications

TOP 3
Kevin Robert Kelly; Frédéric Lozac'h; Alain Mita; Piet Swart; Chris Takimoto; Eugene Tan; Patrick Urban; Felix Waldmeier; Yanfeng Wang; Markus Zollinger; Suraj Anand; Monica Mita
Metabolism of patupilone in patients with advanced solid tumor malignancies.
Yi Jin; Markus Zollinger; Hubert Borell; Alfred G Zimmerlin; Christopher J Patten
CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis.
Markus Zollinger; Hans-Peter Gschwind; Yi Jin; Claudia Sayer; Frédéric Zécri; Stefan Hartmann
Absorption and disposition of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in healthy volunteers: a case of xenobiotic biotransformation following endogenous metabolic pathways.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Zollinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kevin Robert Kelly; Frédéric Lozac'h; Alain Mita; Piet Swart; Chris Takimoto; Eugene Tan; Patrick Urban; Felix Waldmeier; Yanfeng Wang; Markus Zollinger; Suraj Anand; Monica Mita
Metabolism of patupilone in patients with advanced solid tumor malignancies.
Investigational new drugs 2013;31(3):605-15.
2011: Yi Jin; Markus Zollinger; Hubert Borell; Alfred G Zimmerlin; Christopher J Patten
CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis.
Drug metabolism and disposition: the biological fate of chemicals 2011;39(2):191-8.
2011: Markus Zollinger; Hans-Peter Gschwind; Yi Jin; Claudia Sayer; Frédéric Zécri; Stefan Hartmann
Absorption and disposition of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in healthy volunteers: a case of xenobiotic biotransformation following endogenous metabolic pathways.
Drug metabolism and disposition: the biological fate of chemicals 2011;39(2):199-207.
2008: Hans-Peter Gschwind; Felix Waldmeier; Markus Zollinger; Alain Schweitzer; Maximilian Grassberger
Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2008;33(1):9-19.
2006: Gerard J M Bruin; Felix Waldmeier; Klaus Olaf Boernsen; Ulrike Pfaar; Gerhard Gross; Markus Zollinger
A microplate solid scintillation counter as a radioactivity detector for high performance liquid chromatography in drug metabolism: validation and applications.
Journal of chromatography. A 2006;1133(1-2):184-94.
2006: Markus Zollinger; Felix Waldmeier; Stefan Hartmann; Gerhard Zenke; Alfred G Zimmerlin; Ulrike Glaenzel; Jean-Pierre Baldeck; Alain Schweitzer; Stephane Berthier; Thomas Moenius; Maximilian Grassberger
Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(5):765-74.
2005: Hans-Peter Gschwind; Ulrike Pfaar; Felix Waldmeier; Markus Zollinger; Claudia Sayer; Peter Zbinden; Michael Hayes; Rolf Pokorny; Michael Seiberling; Monique Ben-Am; Bin Peng; Gerhard Gross
Metabolism and disposition of imatinib mesylate in healthy volunteers.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(10):1503-12.
2004: Rene Hersperger; Karl-Heinz Buchheit; Salvatore Cammisuli; Albert Enz; Olivier Lohse; Monique Ponelle; Walter Schuler; Alain Schweitzer; Christoph Walker; Hartmut Zehender; Gerhard Zenke; Alfred G Zimmerlin; Markus Zollinger; Lazzaro Mazzoni; John R Fozard
A locally active antiinflammatory macrolide (MLD987) for inhalation therapy of asthma.
Journal of medicinal chemistry 2004;47(20):4950-7.